Investor FAQs

Show All
Where is Adagio Therapeutics’ corporate headquarters?
Adagio is headquartered at 303 Wyman St #303 Waltham, MA, 02451.
When was the company founded?
Adagio was founded and commenced operations in 2020.
When did Adagio go public?
Adagio’s initial public offering (IPO) occurred on August 6, 2021
When is Adagio’s fiscal year-end?
Adagio’s fiscal year ends on December 31st.
How is Adagio’s stock traded?
Adagio is traded on the NASDAQ Global Market under the ticker symbol ADGI, and its CUSIP number is 00534A102.
Who is Adagio’s transfer agent?

American Stock Transfer & Trust Company, LLC.
6201 15th Avenue
Brooklyn, NY 11219
www.astfinancial.com
US Phone: +(800) 937-5449
International Phone: +1 (718) 921-8124

Who are Adagio’s independent auditors?

PricewaterhouseCoopers LLP
101 Seaport Boulevard
Boston, Massachusetts 02210

Who is Adagio’s legal counsel?

Cooley LLP
55 Hudson Yards
New York, NY 10001

Where can I get the latest corporate news releases and financial reports?
Adagio’s press release archives can be viewed here.
How can I view documents Adagio has filed with the Securities & Exchange
Adagio’s SEC filings can be viewed here.
Whom should I contact if I have further questions?
You can submit queries to Adagio’s investor relations department by contacting investors@adagiotx.com.